The Effect of Switching Patients with Symptomatic Benign Prostatic Hyperplasia from Tamsulosin 0.2 mg to 0.4 mgReportar como inadecuado




The Effect of Switching Patients with Symptomatic Benign Prostatic Hyperplasia from Tamsulosin 0.2 mg to 0.4 mg - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Objectives: In 2010,tamsulosin 0.2 mg OD was withdrawn from Thailand and replaced with tamsulosin0.4 mg OD. Therefore, we assessed the impact of this change on the patients,at a men’s health clinic, with lower urinary tract symptoms suggestive ofbenign prostatic hyperplasia LUTS-BPH. Material and Methods: Subjectswere 100 men with BPH who had been taking tamsulosin 0.2 mg as needed for atleast 3 months. The outcome measures were IPSS, AMS and IEFF5 scores anduroflowmetry. Tolerability was evaluated on by adverse events. Changes frombaseline were assessed using the paired t-test. SPSS version 12.0 wasused for statistical analysis, with p



Autor: Supadach Teawongsuwon, Sompol Pempongkosol

Fuente: http://www.scirp.org/



DESCARGAR PDF




Documentos relacionados